ReviewFrontiers in oncology2026

FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance.

Ghaleb Oriquat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.